27212-1-AP

antibody from Proteintech Group

Targeting: TGFBR2 MFS2, TBR-ii, TBRII

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

27212-1-AP

Provider

Proteintech Group

Product name

TGFBR2 antibody

Antibody type

Polyclonal

Description

TGFBR2 antibody (Cat. #27212-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

DAPL1 inhibits epithelial-mesenchymal transition of retinal pigment epithelial cells by regulating the TGF-β/MITF pathway.

You Y, Liu Y, Huang L, Lu WN, Zhang Y, Nie T, Jing M, Hejtmancik JF, Li X, Hou L, Ma X
Experimental eye research 2025 Sep;258:110473

---

RRM2 promotes liver metastasis of pancreatic cancer by stabilizing YBX1 and activating the TGF-beta pathway.

Du Z, Zhang Q, Xiang X, Li W, Yang Q, Yu H, Liu T
iScience 2024 Oct 18;27(10):110864

---

JAK2 inhibitors improve RA combined with pulmonary fibrosis in rats by downregulating SMAD3 phosphorylation.

Wei Y, Wang D, Wu J, Zhang J
International journal of rheumatic diseases 2024 May;27(5):e15164

---

miR-134-3p Regulates Cell Proliferation and Apoptosis by Targeting INHBA via Inhibiting the TGF-β/PI3K/AKT Pathway in Sheep Granulosa Cells.

Huang X, Bao Y, Yang F, Li X, Wang F, Zhang C
Biology 2024 Dec 30;14(1)

---

Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway.

Li J, Wei Q, Song K, Wang Y, Yang Y, Li M, Yu J, Su G, Peng L, Fu B, Yi P
Frontiers in pharmacology 2023;14:1247800

---

YWK-II/APLP2 inhibits TGF-β signaling by interfering with the TGFBR2-Hsp90 interaction.

Tuersuntuoheti A, Li Q, Teng Y, Li X, Huang R, Lu Y, Li K, Liang J, Miao S, Wu W, Song W
Biochimica et biophysica acta. Molecular cell research 2023 Oct;1870(7):119548

---

Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein.

Zhang ZY, Ju CY, Wu LZ, Yan H, Hong WB, Chen HZ, Yang PB, Wang BR, Gou T, Chen XY, Jiang ZH, Wang WJ, Lin T, Li FN, Wu Q
Cell chemical biology 2023 Mar 16;30(3):261-277.e8

---

Exploration the role of INHBA in Hu sheep granulosa cells using RNA-Seq.

Bao Y, Li X, El-Samahy MA, Yang H, Wang Z, Yang F, Yao X, Wang F
Theriogenology 2023 Feb;197:198-208

---

2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside ameliorates bleomycin-induced pulmonary fibrosis via regulating pro-fibrotic signaling pathways.

Huang TT, Chen CM, Chen LG, Lan YW, Huang TH, Choo KB, Chong KY
Frontiers in pharmacology 2022;13:997100

---

Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.

Lian N, Jin H, Zhu W, Zhang C, Qi Y, Jiang M, Mao J, Lu X, Zhao F, Xi B, Qi X, Li Y
Acta histochemica 2022 Dec;124(8):151961

---

Maternal Perinatal Exposure to Dibutyl Phthalate Promotes Ovarian Dysfunction in Adult Female Offspring via Downregulation of TGF-β2 and TGF-β3.

Zhang J, Zhou K, Cheng R, Yang M, Shen X, Luo X, Xu L
Reproductive sciences (Thousand Oaks, Calif.) 2022 Aug;29(8):2401-2413

---

The activation of PPARγ enhances Treg responses through up-regulating CD36/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of TβRII/IL-2Rα.

Miao Y, Zhang C, Yang L, Zeng X, Hu Y, Xue X, Dai Y, Wei Z
Cell communication and signaling : CCS 2022 Apr 7;20(1):48